SE8007640L - Antiarytmiska lekemedel med forlengd verkan vars aktiva huvudbestandsdel er 1'alfa-(bis(1-metyl-etyl)-amino)etyl)-alfa-fenyl-2-pyridinacetamid eller ett salt derav, framstellning derav och kompositioner innehallande ... - Google Patents
Antiarytmiska lekemedel med forlengd verkan vars aktiva huvudbestandsdel er 1'alfa-(bis(1-metyl-etyl)-amino)etyl)-alfa-fenyl-2-pyridinacetamid eller ett salt derav, framstellning derav och kompositioner innehallande ...Info
- Publication number
- SE8007640L SE8007640L SE8007640A SE8007640A SE8007640L SE 8007640 L SE8007640 L SE 8007640L SE 8007640 A SE8007640 A SE 8007640A SE 8007640 A SE8007640 A SE 8007640A SE 8007640 L SE8007640 L SE 8007640L
- Authority
- SE
- Sweden
- Prior art keywords
- salt
- ethyl
- phenyl
- antiarithmic
- salton
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 5
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- 230000003288 anthiarrhythmic effect Effects 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7931443A FR2471784A1 (fr) | 1979-12-21 | 1979-12-21 | Medicaments antiarythmiques a action prolongee dont le principe actif est le a/2-/bis (1-methylethyl) amino/ethyl/-a-phenyl-2-pyridine acetamide ou ses sels, ainsi que le procede de preparation de ces nouveaux medicaments et compositions les renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE8007640L true SE8007640L (sv) | 1981-06-22 |
Family
ID=9233075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8007640A SE8007640L (sv) | 1979-12-21 | 1980-10-30 | Antiarytmiska lekemedel med forlengd verkan vars aktiva huvudbestandsdel er 1'alfa-(bis(1-metyl-etyl)-amino)etyl)-alfa-fenyl-2-pyridinacetamid eller ett salt derav, framstellning derav och kompositioner innehallande ... |
Country Status (13)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1982004392A1 (fr) * | 1981-06-18 | 1982-12-23 | Uclaf Roussel | Procede de preparation de compositions pharmaceutiques a base d'(alpha)-/2-/bis (1-methylethyl) amino/ethyl(alpha)-phenyl 2-pyridine acetamide ou de l'un de ses sels |
| US4789549A (en) * | 1987-03-09 | 1988-12-06 | Warner-Lambert Company | Sustained release dosage forms |
| JPH08143450A (ja) * | 1994-11-14 | 1996-06-04 | Taiyo Yakuhin Kogyo Kk | 徐放化製剤 |
| ME02135B (me) | 2006-03-16 | 2015-04-30 | Euro Celtique Sa | Farmaceutski sferoidi |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3062720A (en) * | 1959-05-20 | 1962-11-06 | Philips Roxane | Sustained release pharmaceutical tablet |
| FR2485M (fr) * | 1961-05-17 | 1964-04-27 | Searle & Co | Nouveaux régulateurs cardiaques. |
| GB1021924A (en) * | 1962-06-22 | 1966-03-09 | Smith Kline French Lab | Improvements in or relating to method of preparing sustained release tablets |
| BE708434A (enrdf_load_stackoverflow) * | 1966-12-22 | 1968-05-02 |
-
1979
- 1979-12-21 FR FR7931443A patent/FR2471784A1/fr active Granted
-
1980
- 1980-10-30 SE SE8007640A patent/SE8007640L/ not_active Application Discontinuation
- 1980-12-12 ZA ZA00807807A patent/ZA807807B/xx unknown
- 1980-12-18 MA MA19224A patent/MA19021A1/fr unknown
- 1980-12-18 JP JP17817480A patent/JPS56118016A/ja active Granted
- 1980-12-19 AU AU65604/80A patent/AU543380B2/en not_active Ceased
- 1980-12-19 PT PT72256A patent/PT72256B/pt unknown
- 1980-12-19 NL NL8006938A patent/NL191171C/xx not_active IP Right Cessation
- 1980-12-19 GB GB8040813A patent/GB2068226B/en not_active Expired
- 1980-12-19 CA CA000367273A patent/CA1151067A/fr not_active Expired
- 1980-12-19 DE DE19803048154 patent/DE3048154A1/de active Granted
- 1980-12-19 BE BE0/203250A patent/BE886774A/fr not_active IP Right Cessation
- 1980-12-19 IT IT50423/80A patent/IT1144024B/it active Protection Beyond IP Right Term
Also Published As
| Publication number | Publication date |
|---|---|
| IT1144024B (it) | 1986-10-29 |
| DE3048154C2 (enrdf_load_stackoverflow) | 1992-03-19 |
| FR2471784A1 (fr) | 1981-06-26 |
| AU543380B2 (en) | 1985-04-18 |
| GB2068226A (en) | 1981-08-12 |
| FR2471784B1 (enrdf_load_stackoverflow) | 1982-12-17 |
| AU6560480A (en) | 1981-06-25 |
| ZA807807B (en) | 1982-01-27 |
| NL191171C (nl) | 1995-03-01 |
| NL191171B (nl) | 1994-10-03 |
| JPS56118016A (en) | 1981-09-16 |
| PT72256A (fr) | 1981-01-01 |
| PT72256B (fr) | 1982-07-15 |
| BE886774A (fr) | 1981-06-19 |
| JPH0141606B2 (enrdf_load_stackoverflow) | 1989-09-06 |
| GB2068226B (en) | 1984-03-21 |
| IT8050423A0 (it) | 1980-12-19 |
| NL8006938A (nl) | 1981-07-16 |
| CA1151067A (fr) | 1983-08-02 |
| DE3048154A1 (de) | 1981-09-03 |
| MA19021A1 (fr) | 1981-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2087090T3 (es) | Nucleosidos pirimidinicos. | |
| NO802352L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| ATE4903T1 (de) | 1-, 6- und 2-substituierte 1-carba-2-penem-3carbons[ure, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| NL960019I1 (nl) | Moforlino-ethylester van mycofenolzuur en derivaten ervan, de bereiding ervan en hun toepassing in farmaceutische samenstellingen. | |
| ES2130111T3 (es) | Derivados de ciclohexano, preparaciones que los contienen y su utilizacion. | |
| JPS5513275A (en) | Prodrug of non-steroid anti-inflammatory drug having improved absorption and anti-inflammatory drug composition comprising it | |
| SE8204918D0 (sv) | Nya 3-amino-pregn-5-en-derivat, deras salter, sett for framstellning och anvendning derav som lekemedel och kompositioner innehallande dem | |
| DE3061693D1 (en) | Secondary amines, their preparation and use in pharmaceutical compositions | |
| ES461399A1 (es) | Procedimiento para preparar esteres de epinina con acidos carboxilicos de cadena ramificada. | |
| SE8303013L (sv) | B-gamma-dihydropolyprenylalkoholderivat och farmaceutisk komposition innehallande en polyprenylforening | |
| SE8007640L (sv) | Antiarytmiska lekemedel med forlengd verkan vars aktiva huvudbestandsdel er 1'alfa-(bis(1-metyl-etyl)-amino)etyl)-alfa-fenyl-2-pyridinacetamid eller ett salt derav, framstellning derav och kompositioner innehallande ... | |
| KR910002437A (ko) | 항염증성 조성물, 항알레르기성 조성물 또는 이들 혼합성질의 조성물 | |
| SE7906011L (sv) | Nya imidazokinoxaliner och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar | |
| KR910700230A (ko) | 신규 히드록실아민 유도체 | |
| ES484718A1 (es) | Un procedimiento para la preparacion de benzopiranos. | |
| GB1250208A (enrdf_load_stackoverflow) | ||
| ES2078838A1 (es) | Procedimiento para preparar una composicion a base de clozapina. | |
| ES475533A1 (es) | Un metodo para la preparacion de formas racemicas y optica- mente activas de 2-(4-difenilil)-n-(dimetilamino-alquil)pro-pionamida | |
| MX159874A (es) | Procedimiento para preparar una composicion farmaceutica a base de fosfolipidos | |
| IL59052A (en) | Hexahydro-1,4-oxazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| ES8105691A1 (es) | Procedimiento para separar d-acido 2-(6-metoxi-2-naftil)- propionico de una mezcla de d-y 1-acidos 2-(6-metoxi-2-naf- til)-propionicos o sus sales | |
| SE7905865L (sv) | Nya acetylenderivat av androsten-4-en, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar | |
| AU7338587A (en) | Pharmaceutical compositions of furosemide, piretanide or lemidosul in a fatty acid alkanolamide base | |
| JPS5640607A (en) | Drug composition | |
| FR2453850A1 (fr) | Nouveaux derives de 16-methoxy-16-methyl-prostaglandine e1 utiles notamment comme agents gastroprotecteurs et leur procede de preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8007640-9 |